| Literature DB >> 35157162 |
Arthur Dunne1, Giles Warrington2,3, Adrian McGoldrick4, Jennifer Pugh4, Michael Harrison5, SarahJane Cullen5.
Abstract
Jockeys are unlike other weight-making athletes as the sport of horse racing requires strict weight management to meet the racing stipulations, protracted working hours and an extended racing season with limited downtime. Several studies have reported on the body composition and bone status of male and female professional and retired jockeys, yet the variety of assessment techniques, lack of standardised testing protocols and classification inconsistency make interpretation and comparison between studies problematic. This review aimed to appraise the existing body composition and bone health evidence in jockeys and evaluate the assessment methods and classification criteria used. Dual-energy X-ray absorptiometry (DXA) has been used most frequently in jockey research to assess body composition and bone status, while various generic skinfold equations have been used to predict body fat percentage. Evidence indicates flat jockeys are now taller and heavier than the data reported in earlier studies. Absolute fat mass has steadily increased in male jockeys in the last decade. The bone status of male jockeys remains a concern as constant low bone density (BMD) is evident in a large percentage of young and experienced professional jockeys. Due to limited studies and variations in assessment methods, further research is required to investigate bone turnover markers in male and female jockeys. A standardised testing protocol using internationally recognised assessment guidelines is critical for the accurate interpretation and evaluation of body composition and bone health measurements. Furthermore, establishing jockey-specific BMD and bone turnover reference ranges should be considered using existing and future data.Entities:
Keywords: Body composition; Body fat; Bone health; Bone mineral density; Bone strength; DXA; Horseracing; Weight making
Year: 2022 PMID: 35157162 PMCID: PMC8844321 DOI: 10.1186/s40798-022-00414-1
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Comparison of body composition and assessment methods in professional and retired jockeysa
| Study (country) | Participants | Body composition | Assessment method | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number (sex) | Age | Body mass (kg) | Height (cm) | BMI (kg m−2) | Body fat % | Lean mass (kg) | Fat mass (kg) | ∑ of 7 (mm) | ||
| Leydon and Wall [ | 6 (m) and 14 (f) flat | 23.5 ± 4.3 (m); 24.5 ± 6.7 (f) | 52.8 ± 2.4 (m); 49.3 ± 3.4 (f) | 162.3 ± 4.4 (m); 156.2 ± 4.0 (f) | 20.1 ± 1.5 (m); 20.2 ± 1.5 (f) | 11.7 ± 2.9 (m); 23.6 ± 3.8 (f) | – | – | – | DXA |
| Wilson et al. [ | 8 (m) and 8 (f) flat | 26.0 ± 5.0 (m); 29.0 ± 8.0 (f) | 57 ± 2.1 (m); 57.3 ± 3.5 (f) | 167.0 ± 4.0 (m); 163.0 ± 5.0 (f) | – | 12.5 ± 2.7 (m); 19.5 ± 2.5 (f) | 45.7 ± 1.2 (m), 42.0 ± 3.3 (f) | – | – | DXA |
| Jackson et al. [ | 79 (m) and 37 (f) app; 69 (m) con | 18.5 ± 1.9 (m) 19.3 ± 2.0 (f) app; 20.7 ± 2.0 con (m) | 52.9 ± 2.9 (m) 51.6 ± 4.0 (f) app; 63.7 ± 3.6 con (m) | 167.0 ± 6.0 (m) 157.0 ± 5.0 (f) app; 176.0 ± 5.0 con (m) | 19.0 ± 1.4 (m) 20.8 ± 1.7 (f) app; 20.6 ± 1.3 con | 14.6 ± 2.3 (m) 24.4 ± 3.7 (f) app; 15.7 ± 2.7 con | 42.5 ± 2.6 (m), 36.4 ± 2.7 (f) app; 50.7 ± 3.1 con (m) | 7.6 ± 1.3 (m), 12.4 ± 2.4 (f) app; 9.9 ± 1.7 con (m) | – | DXA |
| Wilson et al. [ | 32 (m) app | 19.0 ± 1.8 | 56.0 ± 2.9 | 169.0 ± 4.7 | – | – | 45.1 ± 2.6 | 7.2 ± 1.8 | – | DXA |
| Cullen et al. [ | 18 (m) tra; 8 (m) app | 16.0 ± 1.0 tra; 18.0 ± 1.0 app | 55.7 ± 5.5 tra; 54.9 ± 2.9 app | 167.0 ± 5.0 tra; 169.0 ± 4.0 app | 19.9 ± 1.7 tra; 19.2 ± 1.1 app | 8.1 ± 1.7 tra 7.4 ± 1.3 app | – | – | 45.7 ± 7.5 tra; 42.0 ± 8.0 app | Skinfold thickness Withers equation |
| Wilson et al. [ | 17 (m) app; 14 (m) sen flat | 19.0 ± 2.0 app; 32.0 ± 7.0 sen | 56.2 ± 2.0 app; 56.4 ± 3.0 sen | 170.0 ± 5.0 app; 166.0 ± 5.0 sen | – | 13.7 ± 2.6 app; 12.5 ± 1.9 sen | 46.4 ± 2.0 app; 45.7 ± 3.1 sen | 7.5 ± 1.7 app; 6.8 ± 1.4 sen | – | DXA |
| Labadarios et al. [ | 93 (m) flat and NH | 27.8 | 52.9 | 160.9 | – | 11.0 | – | – | – | Skinfold thickness |
| Warrington et al. [ | 17 (m) flat; 10 (m) NH | 26.7 ± 7.6 flat; 28.3 ± 5.3 NH | 53.1 ± 4.1 flat; 66.2 ± 2.9 NH | 160.0 ± 10.0 flat; 173.0 ± 10.0 NH | 19.9 ± 1.3 flat; 22.1 ± 0.8 NH | DXA: 9.0 ± 2.5 flat; 10.4 ± 4.0 NH SK: 7.9 ± 1.7 flat; 9.9 ± 1.6 NH | – | – | 44.3 ± 10.2 flat; 56.1 ± 9.4 NH | DXA and Skinfolds Thickness Withers equation |
| Dolan et al. [ | 17 (m) flat; 10 (m) NH | 26.7 ± 7.6 flat; 28.3 ± 5.3NH | 53.1 ± 4.1 flat; 66.2 ± 2.9 NH | 167.0 ± 10.0 flat; 173.0 ± 10.0 NH | 19.9 ± 1.3 flat; 22.1 ± 0.8 NH | 9 5 ± 2.5 flat; 10.4 ± 4.0 NH | 49.7 ± 6.2 flat and NH | – | – | DXA |
| Hitchens et al. [ | 7 (m) and 1 (f) app + sen | 28.8 ± 10.1 | 55.1 ± 5.9 | 163.4 ± 7.1 | 20.6 ± 1.6 | 14.0 ± 3.5b | – | – | – | DXA |
| Dolan et al. [ | 20 (m) flat and NH | 26.0 ± 3.0 | 61.1 ± 5.4 | 170.0 ± 7.0 | 21.4 ± 1.8 | 11.4 ± 5.6 | 52.5 ± 5.2 | 6.8 ± 3.6 | – | DXA |
| Dolan et al. [ | 14 (m) flat; 16 (m) NH | 25.0 ± 7.0 flat; 24.0 ± 4.0 NH | 54.6 ± 3.6 flat; 64.3 ± 3.3 NH | 165.0 ± 6.0 flat; 172.0 ± 5.0 NH | 20.2 ± 1.6 flat; 21.9 ± 1.2 NH | 8.3 ± 2.9 flat; 13.8 ± 6.0 NH | 49.4 ± 3.8 flat; 53.7 ± 4.3 NH | 4.4 ± 1.5 flat; 8.7 ± 3.9 NH | – | DXA |
| Wilson et al. [ | 9 (m) NH | 24.0 ± 3.1 | 63.2 ± 4.7 | 172.0 ± 5.2 | – | 11.3 ± 2.2 | 51.6 ± 3.7 | 6.9 ± 1.7 | – | DXA |
| Wilson et al. [ | 19 (m) flat; 18 (m) NH | 27.0 ± 5.0 flat; 25.0 ± 5.0 NH | 56.1 ± 2.9 flat; 65.3 ± 2.5 NH | 167.0 ± 5.0 flat; 175.0 ± 5.0 NH | 20.3 ± 1.4 flat; 21.4 ± 1.3 NH | 13.0 ± 3.0 flat; 11.5 ± 3.3 NH | – | 7.4 ± 1.0 flat; 8.2 ± 2.1 NH | – | DXA |
| Dolan et al. [ | 4 (m) flat; 5 (m) NH | 24.0 ± 7.0 flat and NH | 58.2 ± 5.3 flat and NH | 168.0 ± 5.0 flat and NH | 20.7 ± 1.7 flat and NH | 9.0 ± 1.4 flat and NH | – | – | 51.1 ± 8.0 flat and NH | Skinfold thickness Withers equation |
| Wilson et al. [ | 10 (m and f) flat and NH | 32.0 ± 6.0 | 59.2 ± 4.6 | 167.0 ± 8.0 | – | 13.1 ± 5.9 | 47.1 ± 5.3 | 7.3 ± 3.5 | – | DXA |
| O’Reilly et al. [ | 20 (m) flat | 29.3 ± 7.8 | 53.8 ± 3.3 | 162.0 ± 6.0 | 20.5 ± 1.5 | 5.8 ± 2.6 | 50.8 ± 2.5d | 3.2 ± 1.5d | 42.9 ± 11.8 | Skinfold thickness D & W equation |
| Poon et al. [ | 14 (m) flat | 29.1 ± 6.1 | 52.8 ± 3.7 | 161.0 ± 5.0 | 20.3 ± 1.6 | – | – | – | 42.4 ± 9.1 | Skinfold thickness J & P equation |
| Jeon et al. [ | 10 (m) flat | 31.8 ± 3.7 | 50.6 ± 1.9 | 157.5 ± 4.5 | 20.5 ± 1.4 | 14.4 ± 2.3 | 43.3 ± 1.7 | 7.3 ± 1.2 | – | DXA |
| Dunne et al. [ | 35 (m) flat; 37 (m) NH | 27.5 ± 9.6 flat; 27.5 ± 5.4 NH | 56.1 ± 3.2 flat; 65.5 ± 3.4 NH | 167.2 ± 5.5 flat; 175.6 ± 4.5 NH | – | 15.0 flat; 14.6 NH | – | – | 44.1 ± 10.2 flate; 47.7 ± 10.5 NHe | DXA and skinfold thickness |
| Dunne et al. [ | 39 (m) flat; 46 (m) NH | 26.8 ± 9.6 flat; 27.7 ± 5.9 NH | 55.7 ± 3.2 flat; 65.7 ± 3.2 NH | 167.3 ± 5.4 flat; 174.6 ± 4.4 NH | 20.0 ± 1.3 flat; 21.6 ± 1.2 NH | 14.9 ± 3.0 flat; 15.3 ± 3.4 NH | 45.7 ± 3.1 flat; 53.4 ± 3.4 NH | 8.0 ± 1.7 flat; 9.6 ± 2.3 NH | – | DXA |
| Cullen et al. [ | Retired: 7 (m) flat; 12 (m) NH; 9 (m) dual | 61.0 ± 6.0 flat; 59.0 ± 6.0 NH; 58.0 ± 7.0 dual | 65.6 ± 11.0 flat; 77.9 ± 11.4 NH; 74.5 ± 7.0 dual | 163.0 ± 5.0 flat; 167.0 ± 3.0 NH; 166.0 ± 3.0 dual | 24.8 ± 4.0 flat; 28.1 ± 4.1 NH; 27.0 ± 2.7 dual | 23.1 ± 6.8 flat; 27.1 ± 6.1 NH; 26.9 ± 7.3 dual | 42.5 ± 5.3 flat; 49.5 ± 5.2 NH; 47.9 ± 5.2 dual | 14.3 ± 7.0 flat; 20.7 ± 7.4 NH; 19.2 ± 6.2 dual | – | DXA |
| Mackinnon et al. [ | Retired: 209 (m) all; 135 (m) 50+ | 56.1 ± 14.6 all; 64.7 ± 9.9 50+ | – | – | 24.5 ± 2.9 all; 25.0 ± 3.0 50+ | – | – | – | – | Retired Athletes Questionnaire |
Values presented as mean ± SD
f female, m male, NH national hunt, app apprentice, con conditional, sen senior, tra trainee, SK skinfold, dual flat and national hunt riding licence, D & W Durnin & Womersley, J & P Jackson and Pollock, all all jockeys recruited, 50+ jockeys ≥ 50 years of age
aTable is arranged based on sex and racing licence with studies of female jockeys first followed by male apprentice and conditional then senior and retired jockeys
bBased on 5 jockeys
cBaseline measurement of jockeys recruited for study intervention
dEstimated using skinfold prediction equations
eSum of 8 skinfold thickness
Comparison of bone parameter measurements and results in studies of male and female professional and retired jockeysa
| Study (country) | Participants | Assessment method | Bone parameters measured | Results | ||
|---|---|---|---|---|---|---|
| Number (sex) | Age | |||||
| Greene et al. [ | 11 (m) and 14 (f) app | 20.1 ± 4.9 | pQCT | Tibial and radial bone variables: trabecular area and density, BMC, TBA, cortical area and density, SSI | Tibia: cortical area (mm2)—66% proximal: 311.4 ± 40.5 Cortical density (g cm2)—66% proximal: 1163.6 ± 38.1 SSI (mm3) 4% distal 1683.3 ± 123.7; 66% proximal 1953.9 ± 326.8 Radius: cortical area (mm2)—66% proximal 81.4 ± 16.7 SSI (mm3) 4% distal 391.9 ± 69.4; 66% proximal 297.3 ± 88.3 | |
| Silk et al. [ | 17 (m) app | 22.3 ± 5.0 (supp) versus 19.3 ± 1.8 (pla) | pQCT and bone markers | 4% distal tibia: trabecular area, content and density, TD, TBA, bone strength index 66% proximal tibia: cortical content, area, density, thickness, TBA SSI tibia, P1NP, CTX | Trabecular density (mg cm2): 241.0 ± 28.1 (supp); 246.8 ± 33.9 (pla) Trabecular area (mm2): 861.1 ± 160.2 (supp); 854.7 ± 126.7 (pla) Cortical density (mg cm2): 1101.5 ± 24.7 (supp); 1113.4 ± 22.1 (pla) Cortical area (mm2): 267.1 ± 29.3 (supp); 263.4 ± 43.8 (pla) SSI tibia (mm3): 2100.5 ± 329.2 (supp); 2140.0 ± 489.6 (pla) | CTX (ng/L): 371.3 ± 201.0 (supp); 380.0 ± 141.1 (pla) P1NP (μg/L): 104.2 ± 46.4 (supp); 108.9 ± 31.6 (pla) |
| Waldron-Lynch et al. [ | 9 (m) flat; 3 (m) NH | 25.5 ± 5.0 | Bone markers | NTx, fDPD, P1NP, bone ALP, OC | NTx (nmol/mmol)c: 99.4 ± 72.6 fDPD (nmol/mmol)c: 6.98 ± 3.27 P1NP (μg/L): 118.8 ± 76.1 Bone ALP (μg/L): 18.8 ± 10.9 OC (μg/L): 20.8 ± 11.3 | |
| Dolan et al. [ | 20 (m) | 25.9 ± 3.3 | DXA and bone markers | BMD: WB WB, LS (L2–4), FN BMAD: LS (L2–4), FN NTx, P1NP | BMD (g/cm2) WB: 1.134 ± 0.05 LS: 1.11 ± 0.08 FN: 1.06 ± 0.09 BMAD (g/cm3) LS: 0.137 ± 0.01 FN BMAD: 0.39 ± 0.04 | NTx (nmol L−1): − 0.35 ± 0.88 P1NP (ng mL−1): 88.62 ± 46.69 |
| Wilson et al. [ | 19 (m) flat; 18 (m) NH | 27.0 ± 5.0 flat; 25.0 ± 5.0 NH | DXA and bone markers | BMD WB CTx | WB: − 0.87 ± 0.77 flat; − 0.11 ± 1.00 NH | CTx (μg L−1): 0.46 ± 0.21 flat; 0.36 ± 0.14 NH |
| Jackson et al. [ | 79 (m) and 37 (f) app; 69 (m) con | 18.5 ± 1.9 (m) 19.3 ± 2.0 (f) app; 20.7 ± 2.0 (m) con | DXA | BMD and BMC: LS (L1–L4), FN, TH BMAD: LS (L1–L4), FN | BMD (g/cm2) LS: 0.876 ± 0.091 (m); 0.987 ± 0.083 (f) app; 0.969 ± 0.087 con FN: 0.831 ± 0.070 (m); 0.840 ± 0.077 (f) app; 0.935 ± 0.093 con TH: 0.924 ± 0.084 (m) 0.959 ± 0.075 (f) app; 1.017 ± 0.100 con BMAD (g/cm3) LS: 0.114 ± 0.011 (m); 0.132 ± 0.013 (f) app; 0.118 ± 0.011 con FN: 0.155 ± 0.113 (m); 0.176 ± 0.023 (f) app; 0.168 ± 0.023 con LS: 60 [76.0] (m); 6 [16.2] (f) app; 36 [52.2] con FN: 27 [34.2] (m); 3 [8.1] (f) app; 6 [8.7] con TH: 33 [41.8] (m); 1 [2.7] (f) app; 7 [10.1] con LS: 23 [29.1] (m); 1 [2.7] (f) app; 9 [13.0] con FN: 1 [1.3] (m) app | |
| Leydon and Wall [ | 2 (m) and 9 (f) app; 4 (m) and 5 (f) sen | 20.5 ± 3.8 app; 28.7 ± 5.0 sen | DXA | BMD | WB: − 1.80 ± 0.76 LS: − 0.36 ± 1.0 TH: − 0.54 ± 1.1 | |
| Wilson et al. [ | 8 (m) and 8 (f) flat | 25.0 ± 5.0 (m); 29.0 ± 8.0 (f) | DXA | BMD: LS, TH BMD | BMD (g/cm2) LS: 0.90 ± 0.14 (m); 1.02 ± 0.13 (f) TH: 0.89 ± 0.1 (m); 0.87 ± 0.15 (f) LS: − 1.6 ± 1.3 (m); − 0.3 ± 0.8 (f) TH: − 1.2 ± 1.0 (m); − 0.02 ± 0.8 (f) | |
| Wilson et al. [ | 17 (m) app; 14(m) sen flat | 19.0 ± 2.0 app; 32.0 ± 7.0 sen | LS: − 1.3 ± 1.4 app; − 1.5 ± 1.0 sen TH: − 0.9 ± 1.1 app; − 0.8 ± 0.7 sen | |||
| Hitchens et al. [ | 5 (m and f) app and sen | 28.8 ± 10.1 | DXA | BMD: WB | BMD (g/cm2) WB: 1.157 ± 0.07 | |
| Warrington et al. [ | 17 (m) flat; 10 (m) NH | 26.7 ± 7.6 flat; 28.3 ± 5.3 NH | DXA | BMD: WB, LS, TH BMD | BMD (g/cm2) WB: 1.05 ± 0.07 flat; 1.21 ± 0.06 NH LS: 1.12 ± 0.11 flat; 1.22 ± 0.15 NH TH: 0.99 ± 0.1 flat; 1.08 ± 0.13 NH WB: − 1.23 ± 0.99 flat; − 0.16 ± 0.82 NH LS: − 0.91 ± 0.84 flat; − 0.3 ± 1.18 NH TH: − 0.67 ± 0.87 flat; − 0.11 ± 1.01 NH | |
| Dolan et al. [ | 14 (m) flat; 16 (m) NH | 25.0 ± 7.0 flat; 24.0 ± 4.0 NH | DXA | BMD, BMC and BA: WB, LS (L2–4), FN BMAD: LS (L2–4), FN | BMD (g/cm2) WB: 1.09 ± 0.6 flat; 1.17 ± 0.05 NH LS: 1.10 ± 0.09 flat; 1.15 ± 0.1 NH FN: 1.05 ± 0.07 flat; 1.07 ± 0.11 NH BMAD (g/cm3) LS: 0.14 0.01 flat; 0.14 0.01 NH FN: 0.39 ± 0.04 flat; 0.38 ± 0.05 NH | |
| Wilson et al. [ | 10 (m and f) flat and NH | 32.0 ± 6.0 | DXA | LS: − 1.32 ± 0.76 (Pre) TH: − 1.04 ± 1.2 (Pre) | ||
| O’Reilly et al. [ | 20 (m) flat | 29.3 ± 7.8 | DXA | BMD: forearm, calcaneus | BMD (g/cm2) Forearm: 0.57 ± 0.07 (left); 0.56 ± 0.06 (right) Calcaneus: 0.46 ± 0.12 (left); 0.51 ± 0.06 (right) Forearm: 0.02 ± 0.99 (left); − 0.16 ± 1.15 (right) Calcaneus: − 1.43 ± 0.77 (left); − 1.22 ± 0.79 (right) | |
| Poon et al. [ | 14 (m) flat | 29.1 ± 6.1 | DXA | BMD: calcaneus, forearm | BMD (g/cm2) Calcaneus: 0.50 ± 0.06 (left); 0.51 ± 0.07 (right) Forearm: 0.58 ± 0.08 (left); 0.56 ± 0.06 (right) Calcaneus: − 1.60 ± 0.90 (left); − 1.42 ± 0.94 (right) Forearm: − 0.01 ± 1.06 (left); − 0.22 ± 0.92 (right) | |
| Jeon et al. [ | 10 (m) flat | 31.8 ± 3.7 | DXA | BMD: WB BMC | BMD (g/cm2) WB: 1.155 ± 0.126 BMC WB: 0.00 ± 1.35 | |
| Dunne et al. [ | 39 (m) flat; 46 (m) NH | 27.7 ± 5.9 NH; 26.8 ± 9.6 flat | DXA | BMD and BMC: WB, LS (L1–4), FN, TH BMAD: LS (L1–4), FN | BMD (g/cm2) WB: 1.115 ± 0.081 flat; 1.244 ± 0.075 NH LS: 1.072 ± 0.113 flat; 1.163 ± 0.109 NH FN: 1.026 ± 0.115 flat; 1.100 ± 0.118 NH TH: 0.985 ± 0.106 flat; 1.057 ± 0.111 NH BMAD (g/cm3) LS: 0.125 ± 0.014 flat; 0.124 ± 0.012 NH FN: 0.389 ± 0.048 flat; 0.395 ± 0.044 NH LS: 23 [59] flat; 14 [30] NH FN: 10 [26] flat; 3 [7] NH TH: 19 [49] flat; 6 [13] NH LS: 8 [21] flat; 3 [7] NH TH: 2 [5] flat; 1 [2] NH | |
| Cullen et al. [ | 28 (m) flat and NH retired | 59.0 ± 6.0 | DXA and bone markers | BMD: WB, LS, PF P1NP, CTx | BMD (g/cm2) WB: 1.113 ± 0.142 LS: 1.008 ± 0.163 PF: 0.989 ± 0.154 WB: − 1.1 ± 0.8 LS: − 0.7 ± 1.1 PF: − 0.8 ± 0.9 | CTx: 0.395 ± 0.207 P1NP: 39.66 ± 14.43 |
| Mackinnon et al. [ | 135 (m) retired 50+ | 64.7 ± 9.9 | Questionnaire | Self-reported osteoporosis | 7.4% of the retired jockeys reported as having osteoporosis compared to 1.6% of the reference population | |
Values are mean ± SD, f female, m male, NH national hunt, app apprentice, con conditional, sen senior, tra trainee, WB whole body, LS lumbar spine, TH total hip, PF proximal femur, FN femoral neck, BMC bone mineral content, BMD bone mineral density, BMAD bone mineral apparent density, CTx C-terminal telopeptide of type I collagen, P1NP procollagen type 1 amino terminal propeptide, Bone ALP bone alkaline phosphate, OC intact osteocalcin, NTx-1 N-telopeptides of type 1 collagen, pQCT peripheral Quantitative Computed Tomography, TBA total bone area, fDPD free deoxypyridinoline cross-links, Supp supplement group, Pla placebo group, RCT randomised controlled trial, SSI strain strength index, 50+ jockeys ≥ 50 years of age
aTable is arranged based on assessment method and racing licence with studies of pQCT first followed by bone turnover markers and DXA in present-day jockeys then retired jockeys
bBaseline measurement of jockeys recruited for study intervention
cExpressed as a ratio with urine creatinine concentration